Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/american-medical-association/evaluation-of-the-frequency-of-not-relevant-responses-on-the-PutOjaHDnf
References (20)
-
Erik Elm, D. Altman, M. Egger, S. Pocock, P. Gøtzsche, J. Vandenbroucke (2007)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational StudiesPLoS Medicine, 4
-
Barbieri (2019)
Evaluation of the Dermatology Life Quality Index scoring modification, the DLQI-R score, in two independent populations.Br J Dermatol, 180
-
J. Takeshita, J. Gelfand, P. Li, L. Pinto, Xinyan Yu, P. Rao, H. Viswanathan, J. Doshi (2015)
Psoriasis in the U.S. Medicare population: prevalence, treatment, and factors associated with biologic useThe Journal of investigative dermatology, 135
-
T. Nijsten (2012)
Dermatology life quality index: time to move forward.The Journal of investigative dermatology, 132 1
-
Rencz (2019)
Time to revise the Dermatology Life Quality Index scoring in psoriasis treatment guidelines.J Eur Acad Dermatol Venereol, 33
-
Sejal Shah, A. Arthur, Yu-Ching Yang, S. Stevens, A. Alexis (2011)
A retrospective study to investigate racial and ethnic variations in the treatment of psoriasis with etanercept.Journal of drugs in dermatology : JDD, 10 8
-
von Elm (2007)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.Lancet, 370
-
D. Hosmer, S. Lemeshow (2000)
Applied Logistic Regression, Second Edition -
John Barbieri, J. Gelfand (2019)
Evaluation of the Dermatology Life Quality Index scoring modification, the DLQI‐R score, in two independent populationsBritish Journal of Dermatology, 180
-
D. Hosmer, S. Lemeshow (1991)
Applied Logistic Regression -
F. Rencz, F. Rencz, L. Gulácsi, M. Péntek, A. Poór, Miklós Sárdy, P. Holló, Andrea Szegedi, Éva Remenyik, V. Brodszky (2018)
Proposal of a new scoring formula for the Dermatology Life Quality Index in psoriasisBritish Journal of Dermatology, 179
-
Finlay (1994)
Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use.Clin Exp Dermatol, 19
-
J. Barbieri, J. Gelfand (2019)
Influence of "Not Relevant" Responses on the Dermatology Life Quality Index (DLQI) for Patients With Psoriasis in the United States.JAMA dermatology
-
J. Gelfand, J. Wan, K. Duffin, G. Krueger, R. Kalb, J. Weisman, Brian Sperber, M. Stierstorfer, B. Brod, S. Schleicher, B. Bebo, A. Troxel, D. Shin, Jane Steinemann, J. Goldfarb, H. Yeung, A. Voorhees (2012)
Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting.Archives of dermatology, 148 4
-
J. Gelfand, R. Stern, T. Nijsten, S. Feldman, John Thomas, Joseph Kist, T. Rolstad, D. Margolis (2005)
The prevalence of psoriasis in African Americans: results from a population-based study.Journal of the American Academy of Dermatology, 52 1
-
F. Rencz, V. Brodszky, L. Gulácsi, M. Péntek, A. Poór, P. Holló, A. Szegedi, É. Remenyik, M. Sárdy, A. Langenbruch, M. Radtke, M. Gutknecht, M. Augustin (2019)
Time to revise the Dermatology Life Quality Index scoring in psoriasis treatment guidelinesJournal of the European Academy of Dermatology and Venereology, 33
-
G. Kerr, S. Qaiyumi, J. Richards, Hashem Vahabzadeh-Monshie, C. Kindred, S. Whelton, F. Constantinescu (2015)
Psoriasis and psoriatic arthritis in African-American patients—the need to measure disease burdenClinical Rheumatology, 34
-
M. Atkinson, Anusha Sinha, S. Hass, S. Colman, Ritesh Kumar, M. Brod, C. Rowland (2004)
Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic diseaseHealth and Quality of Life Outcomes, 2
-
A. Finlay, G. Khan (1994)
Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical useClinical and Experimental Dermatology, 19
-
J. Takeshita, M. Augustin, E. Jong, K. Lafferty, W. Langholff, R. Langley, C. Leonardi, A. Menter, A. Alexis (2019)
857 Psoriasis-related quality-of-life differs by race/ethnicityJournal of Investigative Dermatology
- Publisher
- American Medical Association
- Copyright
- Copyright 2020 American Medical Association. All Rights Reserved.
- ISSN
- 2168-6068
- eISSN
- 2168-6084
- DOI
- 10.1001/jamadermatol.2019.4659
- Publisher site
- See Article on Publisher Site
Abstract
Key PointsQuestionAre sociodemographic characteristics associated with the frequency of “not relevant” responses on the Dermatology Life Quality Index among patients with psoriasis? FindingsThis cross-sectional study of a cohort of 1733 patients with psoriasis found that the frequency of “not relevant” responses on the Dermatology Life Quality Index was associated with patients’ sociodemographic characteristics. Specifically, single and widowed or divorced marital status and unemployed or disabled employment status were each associated with increased odds of “not relevant” responses. MeaningMore frequent “not relevant” responses among patients with certain sociodemographic characteristics may indicate an underestimation of psoriasis severity and thus potential undertreatment among specific patient groups.
Journal
JAMA Dermatology – American Medical Association
Published: Apr 26, 2020